Top 10 outcomes voted after phase 1
| Item | Outcomes | Panel SuRa high | Panel SuRa low |
| 30 | Faecal diversion or proctectomy | 97 | 0 |
| 75 | Death | 97 | 3 |
| 15 | Development of a new fistula | 89 | 0 |
| 20 | Incontinence to solid stool | 89 | 0 |
| 28 | Perianal-related hospitalisation | 89 | 0 |
| 29 | Surgical reintervention | 89 | 2 |
| 14 | Recurrence of fistula | 86 | 0 |
| 16 | Perianal abscess on clinical assessment after intervention | 86 | 2 |
| 56 | Unable attend school/work | 84 | 0 |
| 19 | Incontinence to liquid stool | 83 | 0 |
| Panel GaNu high | Panel GaNu low | ||
| 75 | Death | 100 | 0 |
| 30 | Faecal diversion or proctectomy | 98 | 0 |
| 15 | Development of a new fistula | 97 | 0 |
| 84 | Medical complications specific to the immunosuppression (eg, opportunistic infections and cancers) | 97 | 0 |
| 14 | Recurrence of fistula | 94 | 0 |
| 20 | Incontinence to solid stool | 94 | 0 |
| 28 | Perianal-related hospitalisation | 94 | 0 |
| 19 | Incontinence to liquid stool | 92 | 0 |
| 56 | Unable attend school/work | 92 | 0 |
| 21 | Pads for continence/leakage | 91 | 0 |
| Panel Pa high | Panel Pa low | ||
| 19 | Incontinence to liquid stool | 96 | 0 |
| 30 | Faecal diversion or proctectomy | 96 | 0 |
| 20 | Incontinence to solid stool | 93 | 1 |
| 16 | Perianal abscess on clinical assessment after intervention | 92 | 6 |
| 15 | Development of a new fistula | 92 | 0 |
| 28 | Perianal-related hospitalisation | 91 | 3 |
| 75 | Death | 91 | 5 |
| 17 | Wound infection | 90 | 0 |
| 39 | Social interaction avoidance | 89 | 6 |
| 29 | Surgical reintervention | 86 | 5 |
Panel GaNu, gastroenterologists and IBD specialist nurses; panel Pa, patients; panel SuRa, colorectal surgeons and radiologists.